Chengbang Wang
Overview
Explore the profile of Chengbang Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang F, Wang C, Chen S, Wei C, Ji J, Liu Y, et al.
Mol Cancer
. 2025 Mar;
24(1):60.
PMID: 40025576
Background: Cancer remains a leading global cause of mortality, making early detection crucial for improving survival outcomes. The study aims to develop a machine learning-enabled blood-derived exosomal RNA profiling platform...
2.
Chen S, Wang C, Zou X, Li H, Yang G, Su X, et al.
Front Genet
. 2024 Nov;
15:1450064.
PMID: 39600316
Background: Aging can impair the ability of elderly individuals to fight infections and trigger persistent systemic inflammation, a condition known as inflammaging. However, the mechanisms underlying the development of inflammaging...
3.
Wang C, Yang G, Feng G, Deng C, Zhang Q, Chen S
Front Immunol
. 2024 Jul;
15:1410603.
PMID: 39044829
Introduction: Hepatocellular carcinoma (HCC), representing more than 80% of primary liver cancer cases, lacks satisfactory etiology and diagnostic methods. This study aimed to elucidate the role of programmed cell death-associated...
4.
Zheng J, Lu W, Wang C, Chen S, Zhang Q, Su C
Aging (Albany NY)
. 2024 Jun;
16(13):10943-10971.
PMID: 38944814
The genomic landscape of clear cell renal cell carcinoma (ccRCC) has a considerable intra-tumor heterogeneity, which is a significant obstacle in the field of precision oncology and plays a pivotal...
5.
Zhang Q, Wang C, Qin M, Ye Y, Mo Y, Meng Q, et al.
Front Immunol
. 2024 Jun;
15:1298087.
PMID: 38903524
Background: Upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BLCA) both originate from uroepithelial tissue, sharing remarkably similar clinical manifestations and therapeutic modalities. However, emerging evidence suggests that identical...
6.
Zhou R, Lu D, Mi J, Wang C, Lu W, Wang Z, et al.
Sci Rep
. 2024 Jun;
14(1):14107.
PMID: 38898043
Disulfidptosis, a newly identified programmed cell death pathway in prostate cancer (PCa), is closely associated with intracellular disulfide stress and glycolysis. This study aims to elucidate the roles of disulfidptosis-related...
7.
Lu W, Zhao L, Wang S, Zhang H, Jiang K, Ji J, et al.
Clin Transl Oncol
. 2024 Apr;
26(9):2369-2379.
PMID: 38602643
Purpose: Machine learning (ML) models presented an excellent performance in the prognosis prediction. However, the black box characteristic of ML models limited the clinical applications. Here, we aimed to establish...
8.
Huang J, Chen J, Wang C, Lai L, Mi H, Chen S
Front Genet
. 2024 Feb;
15:1294381.
PMID: 38348451
Pediatric sepsis (PS) is a life-threatening infection associated with high mortality rates, necessitating a deeper understanding of its underlying pathological mechanisms. Recently discovered programmed cell death induced by copper has...
9.
Zhang H, Ji J, Liu Z, Lu H, Qian C, Wei C, et al.
BMC Med
. 2023 Jul;
21(1):270.
PMID: 37488510
Background: The introduction of multiparameter MRI and novel biomarkers has greatly improved the prediction of clinically significant prostate cancer (csPCa). However, decision-making regarding prostate biopsy and prebiopsy examinations is still...
10.
Wang C, He Y, Zheng J, Wang X, Chen S
Front Immunol
. 2023 May;
14:1130513.
PMID: 37153569
Background: Kidney renal clear cell carcinoma (KIRC) is the most frequently diagnosed subtype of renal cell carcinoma (RCC); however, the pathogenesis and diagnostic approaches for KIRC remain elusive. Using single-cell...